Connect with us

News

Facebook Will Create 10,000 Jobs In The EU To Build Its Metaverse

Facebook decided to invest in the EU because the company believes that European talent is world-leading, supported by first-class universities.

Published

on

facebook will create 10,000 jobs in the eu to build its metaverse
Getty Images

Facebook has announced that it wants to create 10,000 jobs in the European Union (EU) to build its metaverse, a virtual reality space in which users can interact with a computer-generated environment and other users.

The concept of the metaverse can be traced to Neal Stephenson’s 1992 cyberpunk novel Snow Crash. In the novel, the metaverse is a virtual shared space that appears to its users as an urban environment. This space is accessed through personal terminals connected to virtual reality goggles.

Sound familiar? That’s because the metaverse is quickly becoming a reality thanks to companies like Oculus, a subsidiary of Facebook, and the combined effort of developers and content creators from around the world.

By creating thousands of new high-skilled jobs within the EU over the next five years, Facebook wants to accelerate the development of the metaverse to usher in a new phase of interconnected virtual experiences, enabled by technologies like virtual and augmented reality.

“At its heart is the idea that by creating a greater sense of ‘virtual presence,’ interacting online can become much closer to the experience of interacting in person,” said Nick Clegg, Facebook’s vice-president of global affairs. “The metaverse has the potential to help unlock access to new creative, social and economic opportunities”.

According to the official announcement, Facebook decided to invest in the EU because the company believes that European talent is world-leading, supported by first-class universities. Facebook also mentioned the role European policymakers are playing in shaping the internet, so it’s likely that the investment has a political dimension to it.

Also Read: How To Lock Your Facebook Profile (From Mobile & Desktop)

Aware of its tarnished reputation, the social media giant stressed that no single company would own and operate the metaverse — just like no single company owns the internet today. Of course, that doesn’t change anything about the fact that Facebook wants to play a huge role in it.

Earlier this year, Mark Zuckerberg told his employees that Facebook is becoming a metaverse company with the goal of building a set of connected social apps and supporting hardware. The recently released Horizon Workrooms remote collaboration app for the Oculus Quest 2 headset can be seen as an early piece of the much larger puzzle the metaverse will become in the future.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

on

startup orchid plans to find out what's wrong with you before you're born
Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.

Continue Reading

#Trending